Cigna Investments Inc. New lifted its position in shares of Allscripts (NASDAQ:MDRX) by 544.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 113,930 shares of the software maker’s stock after buying an additional 96,244 shares during the quarter. Cigna Investments Inc. New owned about 0.06% of Allscripts worth $1,406,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Mission Wealth Management LP bought a new position in Allscripts during the first quarter worth $135,000. Zeke Capital Advisors LLC bought a new position in Allscripts during the fourth quarter worth $165,000. Canandaigua National Bank & Trust Co. bought a new position in Allscripts during the first quarter worth $145,000. Quantitative Systematic Strategies LLC bought a new position in Allscripts during the fourth quarter worth $182,000. Finally, Avestar Capital LLC bought a new position in Allscripts during the fourth quarter worth $173,000.
MDRX has been the topic of several research analyst reports. Zacks Investment Research raised shares of Allscripts from a “sell” rating to a “hold” rating in a research note on Thursday, January 25th. Wells Fargo set a $19.00 target price on shares of Allscripts and gave the stock a “buy” rating in a research note on Saturday, February 17th. Bank of America assumed coverage on shares of Allscripts in a research note on Tuesday, February 27th. They set a “buy” rating and a $17.00 target price on the stock. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $17.00 price objective on shares of Allscripts in a research note on Sunday, January 28th. Finally, BidaskClub lowered shares of Allscripts from a “hold” rating to a “sell” rating in a research note on Wednesday, April 4th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and thirteen have issued a buy rating to the company. The company has an average rating of “Buy” and an average target price of $16.01.
Allscripts opened at $12.54 on Tuesday, MarketBeat.com reports. The company has a market capitalization of $2.29 billion, a PE ratio of 26.68, a PEG ratio of 1.70 and a beta of 1.24. Allscripts has a 12 month low of $10.78 and a 12 month high of $16.13. The company has a debt-to-equity ratio of 1.53, a current ratio of 1.02 and a quick ratio of 1.02.
Allscripts (NASDAQ:MDRX) last issued its quarterly earnings data on Thursday, May 3rd. The software maker reported $0.16 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.01). Allscripts had a positive return on equity of 7.80% and a negative net margin of 11.34%. The business had revenue of $518.60 million during the quarter, compared to the consensus estimate of $527.34 million. During the same period last year, the company earned $0.13 earnings per share. The business’s quarterly revenue was up 24.9% compared to the same quarter last year. equities research analysts predict that Allscripts will post 0.56 EPS for the current year.
In other Allscripts news, President Richard J. Poulton sold 15,000 shares of the company’s stock in a transaction that occurred on Thursday, March 15th. The stock was sold at an average price of $13.53, for a total value of $202,950.00. Following the completion of the sale, the president now directly owns 505,920 shares in the company, valued at $6,845,097.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Brian Farley sold 5,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 14th. The stock was sold at an average price of $13.73, for a total value of $68,650.00. Following the completion of the sale, the executive vice president now owns 240,672 shares of the company’s stock, valued at $3,304,426.56. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company’s stock.
Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.
Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts (NASDAQ:MDRX).
Receive News & Ratings for Allscripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts and related companies with MarketBeat.com's FREE daily email newsletter.